Market Overview:
The global native bacterial antigens market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for advanced diagnostics, and growing focus on research and development activities. The global native bacterial antigens market is segmented by type, application, and region. By type, the market is divided into inactivated pathogens and purified pathogens. By application, the market is classified into hospitals and clinics, diagnostic laboratories, academic and research institutes,.and others (including point-of-care testing). Geographically,,the global native bacterial antigenmarketis segmentedinto North America,,Latin America,,Europe,,Asia Pacific,,and Middle East & Africa. Some of the key players operating in this market are Thermo Fisher Scientific Inc., Merck KGaA., BD Biosciences Inc., Lonza Group Ltd.
Product Definition:
Native bacterial antigens are the proteins or polysaccharides present on the surface of a bacterium that elicit an immune response. These antigens can be used to diagnose infections, to identify bacteria causing infections, and to develop vaccines.
Inactivated Pathogen:
Inactivated pathogens are heat-labile microorganisms that do not cause disease when consumed in adequate quantity.
1) Listeria innocua (L. Innocua) - This bacterium is found in soil, plants, and animals and can cause food poisoning when consumed by humans.
Purified Pathogen:
Purified pathogen is a product that consists of the protein or DNA of viruses that are capable of causing disease in humans and animals. The purified pathogens can be used as an immunological stimulus for inducing antibodies specific to the virus. These products are also known as allergen extracts, adjuvants, or immunostimulatory agents.
Application Insights:
The hospitals and clinics segment held the largest revenue share of over 60% in 2017. The application of NNBA is widely prevalent in hospitals, clinics and other healthcare facilities to ensure patient safety by detecting and preventing infectious diseases. In addition, growing awareness regarding the benefits associated with the usage of Native Biological Antigens (NNBAs) is expected to drive their demand in this segment over the forecast period.
The diagnostic laboratories segment is anticipated to witness lucrative growth during the study period owing to increasing demand for accurate diagnosis coupled with rising concerns regarding infectious diseases such as HIV, hepatitis A & B, STDs etcetera. Furthermore, a rise in prevalence rates for chronic conditions such as diabetes will further boost market growth during this study period.
Regional Analysis:
North America dominated the global native bacterial antigens market in 2017. This can be attributed to factors such as favorable reimbursement scenario, presence of advanced healthcare infrastructure and high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region. The Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government initiatives for improving public health system, rising disposable income level and growing penetration of private insurance companies in this region.
In addition, an increase in incidence of infectious diseases due its geographical proximity towards emerging economies such as India.
The Latin American market is also estimated promisingly well by its rapidly growing medical tourism industry which offers lucrative opportunities for international players looking forward investing within this regional space.
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and environmental conditions. The increase in the number of people travelling to different parts of the world has also contributed to the spread of various infections and epidemics. This is expected to drive the demand for native bacterial antigens in the coming years.
- Growing awareness about preventive measures: There is a growing awareness among people about preventive measures against various infections and diseases. This has led to an increase in demand for native bacterial antigens for diagnostic purposes.
- Technological advancements: The field of diagnostics is witnessing rapid technological advancements, which is aiding in better detection and treatment of various infections and diseases caused by bacteria strains. This is expected to boost demand for native bacterial antigens over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Native Bacterial Antigens Market Research Report
By Type
Inactivated Pathogen, Purified Pathogen
By Application
Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes
By Companies
The Native Antigen Company, Creative Diagnostics, Microbix Biosystems, SERION Immunologics, Bio-Rad Laboratories, Enzo Life Sciences, Jena Bioscience GmbH, QED Bioscience, Ross Southern Laboratories, AROTEC Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Native Bacterial Antigens Market Report Segments:
The global Native Bacterial Antigens market is segmented on the basis of:
Types
Inactivated Pathogen, Purified Pathogen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- The Native Antigen Company
- Creative Diagnostics
- Microbix Biosystems
- SERION Immunologics
- Bio-Rad Laboratories
- Enzo Life Sciences
- Jena Bioscience GmbH
- QED Bioscience
- Ross Southern Laboratories
- AROTEC Diagnostics
Highlights of The Native Bacterial Antigens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inactivated Pathogen
- Purified Pathogen
- By Application:
- Hospitals and Clinics
- Diagnostic Laboratories
- Academic and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Native Bacterial Antigens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Native bacterial antigens are proteins that are specific to bacteria. These proteins help the immune system identify and attack bacteria.
Some of the major companies in the native bacterial antigens market are The Native Antigen Company, Creative Diagnostics, Microbix Biosystems, SERION Immunologics, Bio-Rad Laboratories, Enzo Life Sciences, Jena Bioscience GmbH, QED Bioscience, Ross Southern Laboratories, AROTEC Diagnostics.
The native bacterial antigens market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Native Bacterial Antigens Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Native Bacterial Antigens Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Native Bacterial Antigens Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Native Bacterial Antigens Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Native Bacterial Antigens Market Size & Forecast, 2018-2028
4.5.1 Native Bacterial Antigens Market Size and Y-o-Y Growth
4.5.2 Native Bacterial Antigens Market Absolute $ Opportunity
Chapter 5 Global Native Bacterial Antigens Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Native Bacterial Antigens Market Size Forecast by Type
5.2.1 Inactivated Pathogen
5.2.2 Purified Pathogen
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Native Bacterial Antigens Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Native Bacterial Antigens Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Diagnostic Laboratories
6.2.3 Academic and Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Native Bacterial Antigens Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Native Bacterial Antigens Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Native Bacterial Antigens Analysis and Forecast
9.1 Introduction
9.2 North America Native Bacterial Antigens Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Native Bacterial Antigens Market Size Forecast by Type
9.6.1 Inactivated Pathogen
9.6.2 Purified Pathogen
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Native Bacterial Antigens Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Diagnostic Laboratories
9.10.3 Academic and Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Native Bacterial Antigens Analysis and Forecast
10.1 Introduction
10.2 Europe Native Bacterial Antigens Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Native Bacterial Antigens Market Size Forecast by Type
10.6.1 Inactivated Pathogen
10.6.2 Purified Pathogen
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Native Bacterial Antigens Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Diagnostic Laboratories
10.10.3 Academic and Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Native Bacterial Antigens Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Native Bacterial Antigens Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Native Bacterial Antigens Market Size Forecast by Type
11.6.1 Inactivated Pathogen
11.6.2 Purified Pathogen
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Native Bacterial Antigens Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Diagnostic Laboratories
11.10.3 Academic and Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Native Bacterial Antigens Analysis and Forecast
12.1 Introduction
12.2 Latin America Native Bacterial Antigens Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Native Bacterial Antigens Market Size Forecast by Type
12.6.1 Inactivated Pathogen
12.6.2 Purified Pathogen
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Native Bacterial Antigens Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Diagnostic Laboratories
12.10.3 Academic and Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Native Bacterial Antigens Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Native Bacterial Antigens Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Native Bacterial Antigens Market Size Forecast by Type
13.6.1 Inactivated Pathogen
13.6.2 Purified Pathogen
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Native Bacterial Antigens Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Diagnostic Laboratories
13.10.3 Academic and Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Native Bacterial Antigens Market: Competitive Dashboard
14.2 Global Native Bacterial Antigens Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 The Native Antigen Company
14.3.2 Creative Diagnostics
14.3.3 Microbix Biosystems
14.3.4 SERION Immunologics
14.3.5 Bio-Rad Laboratories
14.3.6 Enzo Life Sciences
14.3.7 Jena Bioscience GmbH
14.3.8 QED Bioscience
14.3.9 Ross Southern Laboratories
14.3.10 AROTEC Diagnostics
